(Q24240087)

4

0 references

Eveline Nüesch

1

0 references

Peter Jüni

5

0 references

author name string

Anne WS Rutjes

Cochrane Database of Systematic Reviews

2

0 references

language of work or name

1 reference

7 October 2009

0 references

published in

0 references

cites work

Experience with a placebo-controlled randomized clinical trial of a disease-modifying drug for osteoarthritis: the doxycycline trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007323.PUB2

Randomised, blinded, placebo controlled trial of doxycycline for chronic seronegative arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007323.PUB2

Accuracy and precision of joint space width measurements in standard and macroradiographs of osteoarthritic knees

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007323.PUB2

Identifying relevant studies for systematic reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007323.PUB2

Principles of and Procedures for Systematic Reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007323.PUB2

Treatment of destructive arthritic disorders with MMP inhibitors. Potential role of tetracyclines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007323.PUB2

What is "quality of evidence" and why is it important to clinicians?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007323.PUB2

Data extraction errors in meta-analyses that use standardized mean differences

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007323.PUB2

Systematic reviews in health care: Assessing the quality of controlled clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007323.PUB2

Osteoarthritis: rational approach to treating the individual

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007323.PUB2

Comparison of quantitative and semiquantitative indicators of joint space narrowing in subjects with knee osteoarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007323.PUB2

Superiority of the Lyon schuss view over the standing anteroposterior view for detecting joint space narrowing, especially in the lateral tibiofemoral compartment, in early knee osteoarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007323.PUB2

Commentary: Which meta-analyses are conclusive?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007323.PUB2

OARSI-OMERACT definition of relevant radiological progression in hip/knee osteoarthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007323.PUB2

OMERACT-OARSI initiative: Osteoarthritis Research Society International set of responder criteria for osteoarthritis clinical trials revisited.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007323.PUB2

Meta-analysis: chondroitin for osteoarthritis of the knee or hip.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007323.PUB2

Differential patterns of response to doxycycline and transforming growth factor beta1 in the down-regulation of collagenases in osteoarthritic and normal human chondrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007323.PUB2

Glucosamine for pain in osteoarthritis: why do trial results differ?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007323.PUB2

Reduction of the severity of canine osteoarthritis by prophylactic treatment with oral doxycycline

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007323.PUB2

Disease modification in osteoarthritis: Are drugs the answer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007323.PUB2

Activation of recombinant human neutrophil procollagenase in the presence of doxycycline results in fragmentation of the enzyme and loss of enzyme activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007323.PUB2

7 January 2021

Subject retention and adherence in a randomized placebo-controlled trial of a disease-modifying osteoarthritis drug

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007323.PUB2

7 January 2021

Effects of doxycycline on progression of osteoarthritis: results of a randomized, placebo-controlled, double-blind trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007323.PUB2

7 January 2021

Association between concentrations of urinary type II collagen neoepitope (uTIINE) and joint space narrowing in patients with knee osteoarthritis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007323.PUB2

7 January 2021

Design and conduct of clinical trials in patients with osteoarthritis: recommendations from a task force of the Osteoarthritis Research Society. Results from a workshop

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007323.PUB2

7 January 2021